PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sigmund Freud University Vienna, Vienna, Austria.\', \'MVZ Freising Laboratory, Freising, Germany.\', \'Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Munich, Germany.\', \'Cancer Center Dachau, Dachau, Germany.\', \'Fraunhofer Institute of Optronics, System Technologies, and Image Exploitation IOSB, Karlsruhe, Germany.\', \'Department of Obstetrics, Helios Clinic Pasing, München, Germany.\', \'Oncological Center Fürstenfeldbruck, Dachau, Germany.\', \'Oncological Center Donauwoerth, Donauwoerth, Germany.\', \'BioVariance GmbH, Waldsassen, Germany.\', \'Steinbeishochschule Berlin, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/cam4.3435
?:hasPublicationType
?:journal
  • Cancer medicine
is ?:pmid of
?:pmid
?:pmid
  • 33022856
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.47
?:rankingScore_hIndex
  • 27
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 infections in cancer outpatients-Most infected patients are asymptomatic carriers without impact on chemotherapy.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33022856>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33022856>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all